Navigation Links
Register now for the European Congress on Osteoporosis & Osteoarthritis in Bordeaux
Date:12/6/2011

Don't miss out on low early bird rates for the premier bone meeting in 2012. The European Congress on Osteoporosis & Osteoarthritis (IOF-ECCEO12), from March 21-24, 2012 will be held in in the magnificent city of Bordeaux, France. Take advantage of low early bird rates: register by December 9, 2011 at http://www.iof-ecceo12.org

Enjoy a high quality programme led by international experts and key thought leaders...

Plenary lectures:

  • The conundrum of biological ageing - L. Partridge (Servier Honorary lecture)
  • Changes in epidemiology of osteoporotic fractures - C. Cooper
  • Gender specificity, the male paradigm - E. Orwoll
  • How bone is built - E. Seeman (Educational lecture)
  • Is Rheumatoid Arthritis a bone disease? - W.F. Lems
  • Current controversies in primary and secondary fracture prevention - E. McCloskey
  • How long should we treat - C. Roux
  • Risk-benefits of osteoporosis treatment: lessons from cohort or randomized controlled studies - B. Abrahamsen
  • FRAX: where are we now? - J. Kanis
  • Building new bone: is that possible? - S. Papapoulos

  • Meet-the-expert sessions:

  • Efficacy and safety of calcium supplements - S. Boonen
  • Management of osteoarthritis - T. Bardin
  • Sequential therapies - S. Ferrari
  • Sarcopenia and frailty: assessment and management (2 sessions) - A.A. Sayer & Y. Rolland
  • Clinical utility of bone turnover markers - J.C. Souberbielle
  • Avascular necrosis - T. Thomas
  • Obesity and fracture risk - J. Compston
  • Bone disease in primary hyperparathyroidism - J.P. Bilezikian
  • Nutrition and bone - B. Dawson-Hughes
  • Prevalent fracture and quality of life - J. Adachi
  • Whole body vibration - E. McCloskey and more...

  • Special symposia:

  • ESCEO-FIRMO Symposium - Prevention of bone fractures in post-menopausal women treated with aromatase inhibitors for breast cancer
  • ESCEO-FROMO-IOF Symposia
  • - Treatment of glucocorticod-induced osteoporosis (GIOP) - Treatment of osteoporosis in men - Tools to assess frailty and sarcopenia - Antidepressant medications and osteoporosis
  • ESCEO Symposium
  • - Diagnosis and treatment of osteoarthritis: state of the art
  • ESCEO-FROMO Symposium
  • - How to define responders in osteoarthritis?
  • GREES-ESCEO Symposium
  • - Health Claims for Nutriceuticals Products in the Field of Cartilage and Joint
  • ESCEO-ISPOR Symposium
  • - Compliance with osteoporosis medications: Causes of poor adherence; current statuts, clinical and economical consequences and interventions
  • GRIO-SFR Session
  • - Scientific Session jointly organized by the "Groupe de Recherche et d'Information sur les Ostoporoses" (GRIO) and the "Socit Franaise de Rhumatologie" (SFR)

    The program also includes seven informative Satellite Symposia, as well as oral and poster presentations. Several prestigious awards, including for young investigators, will be presented. Further information is available on the meeting website at http://www.iof-ecceo12.org

    Interested in translational bone research?
    The 2nd IOF-ESCEO Pre-Clinical Symposium, will be held from March 23-24, 2012 in conjunction with IOF-ECCEO12. This twoday forum dedicated to basic and translational bone research is free to registrants of IOF-ECCEO12 (or only 150 euro for access to Symposium alone). The Symposium is chaired by Stuart Ralston.

    Submit your abstract:
    Ensure your research is showcased at this internationally renowned congress. All abstracts will be published in 'Osteoporosis International'.
    Abstract Deadline: January 12, 2012

    Complete programme information is available at http://www.iof-ecceo12.org


    '/>"/>

    Contact: L. Misteli
    info@iofbonehealth.org
    International Osteoporosis Foundation
    Source:Eurekalert

    Related biology news :

    1. The Finnish Population Register Centre to Deploy Entrust EAC ePassport CA Solution
    2. Register now for the Society of Interventional Radiologys 34th Annual Scientific Meeting
    3. Last chance for media to pre-register for Europes largest cancer congress: ECCO15-ESMO34
    4. Register now online for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
    5. Registered dietitians play essential role in management of gastric bypass patients
    6. Register now for the IOF Regionals -- 1st Asia-Pacific Osteoporosis Meeting
    7. Registered dietitians play essential role in effective management of diabetes in adults
    8. Researchers register new species using DNA-based description
    9. Maine registered dietitian sends an SOS to Senators Collins and Snowe
    10. Register now! Boston meeting will showcase latest aging discoveries
    11. IOF calls on European citizens to stand tall and speak out for their bones
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/15/2016)... , Dec. 14, 2016 "Increase in ... biometrics market" The mobile biometrics market is expected to ... 49.33 billion by 2022, at a CAGR of 29.3% ... factors such as the growing demand for smart devices, ... transactions. "Software component is expected to grow ...
    (Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
    (Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
    Breaking Biology News(10 mins):
    (Date:1/20/2017)... January 20, 2017 Stock-Callers.com explores ... have influenced the most recent performances of select equities. ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... Grand View Research, global Biotech market size is expected to reach $604.40 ...
    (Date:1/20/2017)... 2017 http://www.Financialbuzz.com - ... leading causes of death worldwide. There were 8.2 million ... cancer related deaths increased gradually over time, the death ... of various cancers continues to drive demand of biological ... Global Market Insights, Inc. cancer biological therapy market size was ...
    (Date:1/19/2017)... 2017 Research and Markets has announced the ... Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... market is projected to reach $15,737 million by 2022 from $6,521 ... 2022. Omic technologies segment accounted for more than ...
    (Date:1/19/2017)... and HOUSTON , Jan. 19, ... today announced the formation of its Medical/Clinical Advisory ... and industry veterans who enhance the range and ... accelerates development of its novel prenatal diagnostic tests.  ... clinical and strategic guidance for the company,s product ...
    Breaking Biology Technology: